SCHEMBL8826264

SCHEMBL8826264

CCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)nc1)c1ncccc1C(=O)OCC

nearest known ligand 0.50

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 20/20 0.50
AGTR2 P50052 20/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7300746 0.90 AGTR1 (0.57) AGTR1AGTR2
SCHEMBL9590184 0.89 AGTR1 (0.62) AGTR1AGTR2
SCHEMBL7305133 0.88 AGTR1 (0.46) AGTR1AGTR2
SCHEMBL9589685 0.85 AGTR1 (0.59) AGTR1AGTR2
SCHEMBL9603591 0.82 AGTR1 (0.50) AGTR1AGTR2
SCHEMBL9424372 0.82 AGTR1 (0.73) AGTR1AGTR2
SCHEMBL9256905 0.81 AGTR1 (0.59) AGTR1AGTR2
SCHEMBL9589993 0.81 AGTR1 (0.65) AGTR1AGTR2
SCHEMBL9592128 0.80 AGTR1 (0.60) AGTR1AGTR2
SCHEMBL9589667 0.80 AGTR1 (0.57) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5594010-A TREATMENT OF HYPERTENSION AND ATHERIOSCLEROSIS BAYER AKTIENGESELLSCHAFT (DE) 1997-01-14 US disclosed